Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
7,617 results
- A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After Bunionectomy: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After Bunionectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder: primary endpoint results, effect estimate with confidence…
- A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepatocellular Carcinoma (HCC): Complete Statistical AnalysisIndependent statistical analysis of A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of…
- A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older: primary endpoint results, effect estimate with confidence interval, sample-size…
- A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A BOOSTER DOSE OF A GROUP B STREPTOCOCCUS 6 VALENT POLYSACCHARIDE CONJUGATE VACCINE (GBS6) IN HEALTHY ADULTS: Complete Statistical AnalysisIndependent statistical analysis of A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A BOOSTER DOSE OF A GROUP B STREPTOCOCCUS 6 VALENT POLYSACCHARIDE CONJUGATE VACCINE (GBS6) IN HEALTHY ADULTS: primary…
- A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML): Complete Statistical AnalysisIndependent statistical analysis of A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML): primary endpoint results, effect estimate…
- A Trial to Investigate the Relative Efficacy, Safety, and Tolerability of Octaplas LG Versus Octaplas SD: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Investigate the Relative Efficacy, Safety, and Tolerability of Octaplas LG Versus Octaplas SD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and…
- A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing’s Sarcoma: Complete Statistical AnalysisIndependent statistical analysis of A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin: Complete Statistical AnalysisIndependent statistical analysis of A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Virtual Cardiometabolic Health Program for African Immigrants: The Afro-DPP Program: Complete Statistical AnalysisIndependent statistical analysis of A Virtual Cardiometabolic Health Program for African Immigrants: The Afro-DPP Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals: Complete Statistical AnalysisIndependent statistical analysis of A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A-PREDICTIndependent statistical analysis of A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for Nephrectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A-TREATIndependent statistical analysis of American Trial Using Tranexamic Acid in Thrombocytopenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02578901).
- AAA CEUSIndependent statistical analysis of Evaluation of Contrast-Enhanced Ultrasound to Detect Endoleaks After Endovascular Aortic Aneurysm Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- AAAA2Independent statistical analysis of Activity, Adiposity, and Appetite in Adolescents 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04028921).
- AAAA2INTIndependent statistical analysis of Activity, Adiposity, and Appetite in Adolescents 2 Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05443347).
- AAINTVAPIndependent statistical analysis of Aerosolized Antibiotics in the Treatment of Ventilator Associated Pneumonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02478710).
- Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu’s Arteritis: Complete Statistical AnalysisIndependent statistical analysis of Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Abatacept in Treating Adults With Mild Relapsing Wegener’s Granulomatosis: Complete Statistical AnalysisIndependent statistical analysis of Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00468208).
- ABATEIndependent statistical analysis of Active Bathing to Eliminate Infection (ABATE Infection) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02063867).
- ABCIndependent statistical analysis of Arrythmia Burden in Cardiac Contractility Modulation (CCM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05704426).
- ABC Mental Health: A Behavioral Study of K-12 Teachers and School Staff: Complete Statistical AnalysisIndependent statistical analysis of ABC Mental Health: A Behavioral Study of K-12 Teachers and School Staff: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ABD- BINDERIndependent statistical analysis of Abdominal Binder to Reduce Pain and Seroma Formation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01673568).
- ABEMA Alone or in COMBO With MK-6482: Complete Statistical AnalysisIndependent statistical analysis of ABEMA Alone or in COMBO With MK-6482: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04627064).
- ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis: Complete Statistical AnalysisIndependent statistical analysis of Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size…
- Ablate-NCSIndependent statistical analysis of Cardioneuroablation for Neurocardiogenic Syncope: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02009982).
- ABLATORIndependent statistical analysis of ABLATOR Ablation Observational Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02344173).
- Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI: Complete Statistical AnalysisIndependent statistical analysis of Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- ABSORB (Amount of Blueberries So Older Adults Reap Benefits): Complete Statistical AnalysisIndependent statistical analysis of ABSORB (Amount of Blueberries So Older Adults Reap Benefits): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05937165).
- ABSORB EXTENDIndependent statistical analysis of ABSORB EXTEND Clinical Investigation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01023789).
- Absorb IV Randomized Controlled Trial: Complete Statistical AnalysisIndependent statistical analysis of Absorb IV Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02173379).
- Absorption Comparison on Equivalency Value of Genepro Gen2: Complete Statistical AnalysisIndependent statistical analysis of Absorption Comparison on Equivalency Value of Genepro Gen2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02919657).
- Absorption, Distribution, Metabolism and Excretion of [14C]-Labeled BIA 9-1067 and Metabolites: Complete Statistical AnalysisIndependent statistical analysis of Absorption, Distribution, Metabolism and Excretion of [14C]-Labeled BIA 9-1067 and Metabolites: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox® in Patients With Sickle Cell Disease: Complete Statistical AnalysisIndependent statistical analysis of Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox® in Patients With Sickle Cell Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users: Complete Statistical AnalysisIndependent statistical analysis of Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ABY-029Independent statistical analysis of A Microdose Evaluation Study of ABY-029 in Recurrent Glioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02901925).
- AC-170Independent statistical analysis of Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- AC105Independent statistical analysis of AC105 in Patients With Acute Traumatic Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01750684).
- Academic Stress and Proinflammatory Cytokines: Omega-3 Intervention: Complete Statistical AnalysisIndependent statistical analysis of Academic Stress and Proinflammatory Cytokines: Omega-3 Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00519779).
- Acalabrutinib, Umbralisib, and Ublituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Acalabrutinib, Umbralisib, and Ublituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Acamprosate to Reduce Symptoms of Alcohol Withdrawal: Complete Statistical AnalysisIndependent statistical analysis of Acamprosate to Reduce Symptoms of Alcohol Withdrawal: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00106106).
- Acamprosate vs. Placebo in Bipolar Alcoholics: Complete Statistical AnalysisIndependent statistical analysis of Acamprosate vs. Placebo in Bipolar Alcoholics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00466661).
- Accelerated Theta Burst Stimulation for Inpatients With Bipolar Disorder: Complete Statistical AnalysisIndependent statistical analysis of Accelerated Theta Burst Stimulation for Inpatients With Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04058249).